Chronic Kidney Disease (CKD) Drugs Market is projected to reach USD 23.8 Billion, garnering a 4.2% CAGR from 2024 to 2034: Transparency Market Research, Inc.
24 sept. 2024 08h32 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The global chronic kidney disease (CKD) drugs market (만성신장질환(CKD) 치료제 시장) was projected...
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
24 sept. 2024 08h00 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
Tea Extract Market is expected to generate a revenue of USD 8.23 Billion by 2031, Globally, at 7.67% CAGR: Verified Market Research®
23 sept. 2024 10h00 HE
|
Verified Market Research
Lewes, Delaware, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Global Tea Extract Market Size is projected to grow at a CAGR of 7.67% from 2024 to 2031, according to a new report published by Verified...
Labviva Introduces Real Time Inventory Management System for Life Sciences Purchasing
19 sept. 2024 09h00 HE
|
Labviva
Labviva, the leading AI procurement platform for life sciences, today announced the general availability of its automated Inventory Management System.
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
19 sept. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brain Aging
18 sept. 2024 11h07 HE
|
Io Therapeutics, Inc.
Io Therapeutics, Inc., presented on IRX4204 for treatment of brain aging, at the FASEB Conference on Cellular and Molecular Mechanisms of Brain Aging
Erythropoietin Drugs Market Estimated to Reach USD 14.3 billion, Advancing at a CAGR of 3.8% by 2034: Transparency Market Research Inc.
18 sept. 2024 07h05 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The global erythropoietin drugs market is estimated to surge at a CAGR of 3.8% from 2024...
Fairway Consulting Group Appoints Brennan Clark as Vice President of Executive Search
17 sept. 2024 13h25 HE
|
Fairway Consulting Group
Fairway Consulting Group (FCG) appoints Brennan Clark as Vice President of Executive Search.
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
17 sept. 2024 06h30 HE
|
ANEW MEDICAL, INC.
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
ONL Therapeutics Closes $65 Million in Oversubscribed Series D Financing
13 sept. 2024 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...